Tumor Marker Blood Test Doctors Abroad — Page 6

Dr. Ella Tepper serves as the Chief Physician of the Oncology Center at Assuta Medical Center. She specializes in oncology and oversees critical diagnostic screenings like the tumor marker blood test.

• Leading oncologist at Israel's largest private hospital
• Expert in identifying blood-based signs of cancer growth
• Heads the oncology department to ensure diagnostic accuracy
• Coordinates oncology care for international patients

Dr. Zohar Dotan is the Head of Urology at Sheba Medical Center. He uses tumor marker blood tests alongside genetic profiling to create precise cancer treatment plans.

• Holds a PhD in Genetics for deep insight into cancer markers
• Fellowship trained in urologic oncology at Memorial Sloan Kettering in New York
• Leads the Israeli Uro-Oncology Society – sets national standards for cancer care
• Authored 50+ publications and received awards from the American Association of Clinical Surgery
• Specializes in molecular tumor profiling to select the most effective treatment

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.

Jacob Cohen is a gynecologist at Assuta Medical Center. He specializes in endoscopic and laparoscopic operations to treat female reproductive health issues.

• Performs minimally invasive procedures to view and treat internal organs
• Specialist in gynecological surgery for complex cases
• Works at Assuta Medical Center, a leading private hospital in Israel

Dr. Ofer Spielberg is an expert oncohematologist at Assuta Medical Center. He specializes in the blood disorders and cancers found during tumor marker blood tests.

• Practices at Assuta Medical Center – Israel's largest private healthcare provider
• Expert in hematology – the study and treatment of blood-related diseases
• Focuses on identifying cancer cells and abnormalities in blood samples

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Joseba Rebollo Liceaga is a clinical oncologist at Quirónsalud Alicante. He focuses on personalized cancer treatments and gene-based therapies for metastatic breast cancer. Dr. Rebollo Liceaga teaches as a professor of Multidisciplinary and Personalized Oncology. He treats various conditions, including prostate, colon, and thyroid cancers.

• Former Head of Oncology at Clínica San Miguel and Hospital General de Villalba.
• Researches electrochemotherapy and multidisciplinary approaches for complex cases.
• Practices at JCI-accredited Quirónsalud Torrevieja, a leading center in southeastern Spain.
• Expert in diagnostics using PET-CT, mammography, and tumor marker blood tests.

Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.

• Authored over 130 scientific publications on hemato-oncology and cellular therapy.
• Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
• Leads allogeneic and autologous bone marrow transplantation programs.
• Served as the Chairman of the Israeli Lymphoma Study Group.

Dr. Avichai Shimoni is the Director of Bone Marrow Transplantation at Sheba Medical Center. He treats complex blood cancers. He completed a specialized fellowship at the MD Anderson Cancer Center. Dr. Shimoni uses allogeneic and autologous transplants for high-risk patients. He is a professor and Chairman of Hematology at Tel Aviv University.

• Named among Israel’s Best Doctors by Forbes for 2025 and 2026.
• Authored over 250 scientific papers on cellular therapies and transplantation.
• Provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.

• Authored over 100 scientific publications and landmark myeloma studies.
• Completed fellowships at MD Anderson and University of Arkansas for Medical Sciences.
• Performs CAR-T cell therapy and bone marrow transplantations.
• Works at Sheba Medical Center, ranked 7th worldwide in 2026 by Newsweek.

Dr. Eytan Aharon Ben-Ami leads the Oncology Division at Sheba Medical Center in Israel. He specialized in sarcoma and bone oncology at the Dana-Farber Cancer Institute. Dr. Ben-Ami founded the Sheba Clinical Research Organization to advance cancer studies. He treats rare bone tumors and soft tissue sarcomas with personalized protocols.

• Heads the Early-Phase Clinical Trials Unit for innovative cancer therapies.
• Authored over 40 scientific publications on molecular mechanisms and early detection.
• Leads Phase I trials in targeted therapy and immunotherapy for rare cancers.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

• Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
• Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
• Authored over 280 scientific publications on personalized radiation protocols.
• Completed radiation oncology fellowship training at Thomas Jefferson University.

Professor Kim Tae Joong is a specialist in gynecologic oncology at Samsung Medical Center. He uses tumor marker blood tests to detect and monitor reproductive cancers.

• Serves as a professor at Sungkyunkwan University School of Medicine
• Expert in identifying biomarkers for gynecologic malignancies
• Focuses on minimally invasive approaches for female reproductive health
• Member of the Korean Society of Gynecologic Oncology

Professor Schoppmann heads the Gastroesophageal Tumor Unit at Vienna General Hospital. He specializes in the surgical treatment of gastric and esophageal cancers.

• Coordinates tumor marker blood test screening for gastrointestinal cancers
• Published over 240 specialized articles in major medical journals
• Directs surgical functional testing to evaluate digestive system performance
• General Secretary of the Austrian Society of Surgical Oncology
• Associate Professor of Surgery at the Medical University of Vienna

Dr. Kim Taegyun is a gastroenterologist. He focuses on pancreatobiliary diseases and cancers, including pancreatitis, pancreatic cysts and cancer, cholecystitis, gallstones (cholelithiasis), and biliary tract cancer. He also performs advanced endoscopy, including ERCP. He treats gastrointestinal tumors, stomach and colon polyps, stomach cancer, and submucosal tumors (SMT).

Education and training: MD, Jeonbuk National University College of Medicine. MS in Medicine, University of Ulsan. Internship, Jeonbuk National University Hospital. Residency in Internal Medicine, Veterans Health Service Medical Center. Fellowships in Gastroenterology, Inje University Haeundae Paik Hospital and Asan Medical Center.

Career: Attending physician and specialist at Gwangju Veterans Hospital and the Veterans Health Service Medical Center.

Dr. Elad Jacoby is a pioneer of pediatric CAR T–cell therapy in Israel. He heads the Pediatric Cell Therapy Center at Sheba Medical Center. Dr. Jacoby specializes in treating relapsed and high-risk pediatric leukemias and lymphomas. He completed fellowships at Johns Hopkins and the U.S. National Cancer Institute.

• Medical Director of the Advanced Biotherapy Center at Sheba Medical Center.
• Authored over 240 scientific publications in pediatric hemato-oncology.
• Board-certified in both Pediatrics and Pediatric Hematology and Oncology.
• Leads the integration of CAR T–cell therapy with bone marrow transplantation.

Dr. Song Hwayeong is a gastroenterologist. Areas of focus include gastrointestinal cancers (stomach and esophageal) and advanced endoscopy (gastroscopy, colonoscopy, ESD, and polypectomy). Dr. Song also treats digestive and liver diseases, including GERD, gastritis, hepatitis, H. pylori infection, and liver disease.

Dr. Song completed a fellowship in Gastroenterology at Inje University Ilsan Paik Hospital. Dr. Song has served as Clinical Professor at Inje, Gachon, and Inha University Colleges of Medicine. Dr. Song is Director of the Gastroenterology Center at Naeun Hospital.

Accreditations: full member of the Korean Association of Internal Medicine, the Korean Society of Gastrointestinal Endoscopy, and the Korean Gastroenterology Association. Doping Committee Member, WKBL.

Selected papers: cryptogenic hepatocellular carcinoma; primary biliary cirrhosis with overlap syndromes; therapy for lamivudine-resistant chronic hepatitis B; and clevudine in HBV-related cirrhosis.

Dr. Selime Aydogdu is a specialist in pediatric hematology and oncology. She is known for her work in improving early cancer detection in children. Dr. Aydogdu has given many presentations and led discussions on recognizing early cancer symptoms. Her efforts have raised awareness in her field.

Her work has helped achieve better diagnostic results and higher survival rates for children. Dr. Aydogdu is dedicated to education and advocacy. She is a respected member of the pediatric oncology community.

Dr. Pak Seongjin is a gastroenterologist. He focuses on endoscopy and advanced procedures such as gastroscopy, colonoscopy, polypectomy, and ESD. He also treats digestive and liver diseases, including cirrhosis, pancreatitis, hepatitis, and Helicobacter pylori infection.

He earned his M.D. and M.S. in Internal Medicine from Chung-Ang University. He completed his internal medicine residency and a gastroenterology fellowship at Chung-Ang University Hospital.

He is a clinical professor at Gachon University College of Medicine and Inha University College of Medicine. He is a full member of the Korean Association of Internal Medicine, the Korean Society of Gastrointestinal Endoscopy, the Korean Gastroenterology Association, and the Korean Pancreatobiliary Association.